Picture of Aviva logo

AV. Aviva News Story

0.000.00%
gb flag iconLast trade - 00:00
FinancialsConservativeLarge CapTurnaround

REG - Aviva PLC - Rule 2.9 Announcement

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250523:nRSW0601Ka&default-theme=true

RNS Number : 0601K  Aviva PLC  23 May 2025

 

 

 

 

 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR
INDIRECTLY, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE
A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION

23 May 2025

 

Aviva plc

Rule 2.9 Announcement

 

 

In accordance with Rule 2.9 of the City Code on Takeovers and Mergers (the
"Code"), Aviva plc ("Aviva") confirms that as at 23 May 2025, it had
2,678,835,396 issued ordinary shares of 32 17/19 pence each in issue and
admitted to trading. Each ordinary share carries the right to one vote in
relation to all circumstances at general meetings of Aviva. Aviva does not
hold any ordinary shares in treasury. The International Securities
Identification Number (ISIN) is GB00BPQY8M80.

The total number of shares attracting voting rights in the Company is
therefore 2,678,835,396. The above figure may be used by shareholders to
determine the percentage of issued share capital they hold in the Company and
if they are required to notify their interest in, or a change to their
interest in, the Company under the FCA's Disclosure Guidance and Transparency
Rules.

Aviva has a sponsored American Depositary Receipts ("ADR") programme for which
Citibank Shareholder Services acts as the sponsored depositary bank. One ADR
represents two ordinary shares of the Company. The ADRs trade on OTC US. The
trading symbol for these ADRs is AVVIY and the ISIN is US05382A3023.

 

-ends-

 

 Enquiries:
 Media:
 Andrew Reid         +44 (0)7800 694 276
 Sarah Swailes       +44 (0)7800 694 859

 Analysts:
 Greg Neilson        +44 (0)7800 694 564
 Joel von Sternberg  +44 (0)7384 231 238
 Michael O'Hara      +44 (0)7387 234 388

 

 

 Citigroup Global Markets Limited (Joint Financial Adviser and Joint Corporate
 Broker to Aviva)
 Peter Brown / Sian Evans / Peter Catterall / Michael Lamb  +44 (0)20 7986 4000

 Goldman Sachs International (Joint Financial Adviser and Joint Corporate
 Broker to Aviva)
 Anthony Gutman / Nimesh Khiroya / Bertie Whitehead         +44 (0)20 7774 1000

 

Disclaimer

Citigroup Global Markets Limited ("Citi"), which is authorised by the
Prudential Regulation Authority and regulated in the UK by the Financial
Conduct Authority and the Prudential Regulation Authority is acting as
financial adviser exclusively for Aviva and for no one else in connection with
the matters described in this announcement, and will not be responsible to
anyone other than Aviva for providing the protections afforded to its clients
nor for providing advice in relation to the matters referred to in this
announcement. Neither Citi nor any of its affiliates, directors or employees
owes or accepts any duty, liability or responsibility whatsoever (whether
direct or indirect, consequential, whether in contract, tort, in delict, under
statute or otherwise) to any person who is not a client of Citi in connection
with this announcement, any statement contained herein or otherwise.

Goldman Sachs International, which is authorised by the Prudential Regulation
Authority and regulated by the Financial Conduct Authority and the Prudential
Regulation Authority in the United Kingdom, is acting exclusively for Aviva
and no one else in connection with the matters referred to in this
announcement and will not be responsible to anyone other than Aviva for
providing the protections afforded to clients of Goldman Sachs International,
or for providing advice in connection with the matters referred to in this
announcement.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  RTTAJMFTMTTTBTA

Recent news on Aviva

See all news